On May 30, Nabil G. Seidah, a researcher at the Montreal Clinical Research Institute (IRCM), became the first Quebec researcher as well as the second in Canada to be awarded the prestigious 2018 Grand Prix scientifique of the Lefoulon-Delalande-Institute of France Foundation. The Director of the IRCM’s Biochemical Neuroendocrinology Research Unit shares this honour, which carries a prize of €600,000, with Professors Catherine Boileau, of Paris Diderot University, and Helen H. Hobbs, of Southwestern University, in Texas.
Created in 2002, the Grand Prix scientifique of the Lefoulon-Delalande-Institut de France Foundation is awarded annually to scientists who have made an important contribution in physiology, biology or cardiovascular medicine. This honour is conferred to Nabil G. Seidah as well as Professor Boileau and Professor Hobbs in recognition of their research, which led to the identification and characterization of the PCSK9 protein, a major regulator of cholesterol metabolism. Nowadays, PCSK9 inhibitors are used as drugs to control the level of cholesterol.
Nabil G. Seidah is the author of over 720 scientific publications and has been awarded many honours. He is an Officer of the Ordre national du Québec, a member of the Order of Canada as well as a Fellow of the Royal Society of Canada. He is also the recipient of the 2011 Wilder-Penfield Prix du Québec.